Market Overview

Why Celsion's Stock Is Ripping Higher Today


Celsion Corporation (NASDAQ: CLSN) shares are trading at their highest level since early July after the company terminated a stock sale agreement.

Celsion revealed in SEC filing it has notified Lincoln Park Capital Fund regarding termination of the stock purchase agreement signed between both parties on Sept. 8. Celsion was vested with the right to sell to Lincoln Park Capital up to $26 million of shares of the company over the 36-month term, according to the 2020 agreement.

Celsion is a fully integrated oncology company focused on developing a portfolio of innovative cancer treatments, including immunotherapies, DNA-based therapies and directed chemotherapies.

At last check, Celsion shares were rallying 30.98% to $1.67.


Related Articles (CLSN)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks Offerings Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at